August 18, 2016
Since Botox emerged as a cosmetic treatment in the 1990s, people have been trying to find a way to deliver its wrinkle-eliminating effects without the need for needles.
That dream may soon be achieved.
Botox-maker Allergan has spent $90 million to acquire Anterios, a biotech firm that’s developing a topical formulation of the botulinum toxin.
Anterios specializes in botulinum toxin-based prescription drugs and has developed technology for the delivery of Botox and other neurotoxins through the skin.
You’ll still need the services of a qualified practitioner to administer the cream – botulinum is a nerve toxin and needs to be carefully controlled. But needlephobics will be able to get their Botox dose in the form of a lotion instead of flinching as a tiny needle is poked into their crows’ feet.
Comments will be approved before showing up.